BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 8778155)

  • 1. Relation between vitamin D and adolescents' serum prolactin.
    Amanzholkyzy A; Donayeva A; Kulzhanova D; Abdelazim IA; Abilov T; Baubekov Z; Samaha II
    Prz Menopauzalny; 2023 Dec; 22(4):202-206. PubMed ID: 38239397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Serum Prolactin and Thyroid Stimulating Hormone Concentration in Infertile Women: A Systematic Review and Meta-Analysis.
    Ramadras DD; Che Soh Yusof NAA; Yaacob NM; Wan Norlina WA; Hanisah AH
    Malays J Med Sci; 2024 Feb; 31(1):14-32. PubMed ID: 38456102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study.
    Andersen M; Hansen TB; Bollerslev J; Bjerre P; Schrøder HD; Hagen C
    J Endocrinol Invest; 1995 Dec; 18(11):840-6. PubMed ID: 8778155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man.
    Ekman AC; Vakkuri O; Ekman M; Leppäluoto J; Ruokonen A; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2627-32. PubMed ID: 8675588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pituitary-thyroid axis in acromegaly.
    Eskildsen PC; Kruse A; Kirkegaard C
    Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of the pituitary-thyroid axis in acromegalic subjects during prolonged intermittent and pulsatile treatment with octreotide].
    Cuttica CM; Fazzuoli L; Cariola G; Carraro A; Porcella E; Giusti M; Giordano G
    Recenti Prog Med; 1994 Jan; 85(1):7-12. PubMed ID: 8184183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study.
    Hansen TB; Gram J; Bjerre P; Hagen C; Bollerslev J
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):323-9. PubMed ID: 7955439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
    Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC
    Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and prolactin secretion by dispersed cell cultures of a normal human pituitary: effects of thyrotrophin releasing hormone, theophylline, somatostatin, and 2-bromo-alpha-ergocryptine.
    Adams EF; Brajkovich IE; Mashiter K
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):345-51. PubMed ID: 6117169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of growth hormone release in humans by somatostatin.
    Siler TM; VandenBerg G; Yen SS; Brazeau P; Vale W; Guillemin R
    J Clin Endocrinol Metab; 1973 Oct; 37(4):632-4. PubMed ID: 4742541
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.